Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02328677 · ClinicalTrials.gov registry record
ColoCare Study - Colorectal Cancer Cohort
A clinical trial of Colorectal Cancer, sponsored by University of Utah.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 7
- Study locations
NCT02328677 is a study of Colorectal Cancer that is actively recruiting participants, run by University of Utah. The registered enrollment target is 5,000 participants, above the 1,498-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (234% higher). The trial reports 7 study locations across 7 states.
The verdict
NCT02328677, a study of Colorectal Cancer, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 7
- Study locations
Study Summary
ColoCare is an international prospective cohort study of stage I-IV colorectal cancer patients (ICD-10 C18-C20).
Conditions Studied
Study Locations (7)
California
- Cedars-Sinai Medical Center - Los Angeles
Florida
- Lee H. Moffitt Cancer Center - Tampa
Missouri
- Washington University School of Medicine - St Louis
Tennessee
- University of Tennessee - Knoxville
Utah
- Huntsman Cancer Institute - Salt Lake City
Washington
- FHCRC - Seattle
Baden-Wurttemberg
- University Hospital Heidelberg - Heidelberg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2007-03 |
| Est. Completion | 2030-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02328677
The ClinicalTrials.gov registry entry for NCT02328677 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,498-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (234% higher). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT02328677 reports 7 study locations spanning 7 distinct geographic areas - top geographies include California, Florida, Missouri.
Frequently Asked Questions
What is clinical trial NCT02328677 about?
NCT02328677 is a clinical study titled "ColoCare Study - Colorectal Cancer Cohort". ColoCare is an international prospective cohort study of stage I-IV colorectal cancer patients (ICD-10 C18-C20).
What is the current status of trial NCT02328677?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2007-03. Estimated completion is 2030-10.
What conditions does trial NCT02328677 study?
This clinical trial studies the following conditions: Colorectal Cancer.
Who is sponsoring clinical trial NCT02328677?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02328677 being conducted?
This trial has 7 study locations across California, Florida, Missouri, Tennessee, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.